Sökning: onr:"swepub:oai:DiVA.org:uu-70031" >
Preoperative serum ...
Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer
-
Eskelinen, M. (författare)
-
Nordén, T. (författare)
-
Lindgren, A. (författare)
-
visa fler...
-
Wide, L. (författare)
-
- Adami, Hans-Olov (författare)
- Karolinska Institutet
-
- Holmberg, Lars (författare)
- Uppsala universitet,Institutionen för kirurgiska vetenskaper,Gastrointestinal Surgery
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2004
- 2004
- Engelska.
-
Ingår i: European Journal of Surgical Oncology. - : Elsevier BV. - 0748-7983 .- 1532-2157. ; 30:5, s. 495-500
- Relaterad länk:
-
http://www.ncbi.nlm....
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- AIMS: We investigated the association between preoperative serum levels of follicle stimulating hormone (FSH) and the prognosis in women with invasive breast cancer. METHODS: Serum levels of FSH were measured in 182 premenopausal and 581 peri- or postmenopausal women with invasive breast cancer. They were followed for a mean time of 84 months. The study endpoint was death from breast cancer (182 events). Analyses were stratified on menopausal status. RESULTS: None of the estimates showed a statistically significant result. In both pre- and postmenopausal women there was a nominally higher probability of survival with a higher FSH level. Point estimates in multivariate analysis incorporating age, tumour diameter, axillary lymph status, estrogen and progesterone receptor content and year of treatment indicated a stronger association with FSH levels in premenopausal than postmenopausal women (relative hazard 0.63 or 0.85, respectively in the highest compared with the lowest quartile). CONCLUSION: We did not find any statistically significant association between preoperative serum level of FSH and prognosis. Today, FSH is not a clinical target for intervention or a clinically useful prognostic factor and the results of clinical studies up to date can only be used for motivation of further experimental laboratory research.
Nyckelord
- Adult
- Aged
- Breast Neoplasms/*blood/*diagnosis/epidemiology
- Comparative Study
- Female
- Follicle Stimulating Hormone/*blood
- Follow-Up Studies
- Humans
- Middle Aged
- Multivariate Analysis
- Neoplasm Staging
- Postmenopause/blood
- Premenopause/blood
- Preoperative Care
- Prognosis
- Prospective Studies
- Risk Factors
- Statistics
- Survival Analysis
- Sweden/epidemiology
- Tumor Markers; Biological/*blood
- Women's Health
- MEDICINE
- MEDICIN
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas